In Depth 21 Mar 2024 Biotech in France: What’s holding back progress and how to move forward? …rare diseases in Europe. However, France’s biotech ecosystem faces a set of challenges. While France’s position offers a glimpse into the potential for groundbreaking health solutions, it also opens up… March 21, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 9 Nov 2022 PrecisionLife supports Sosei Heptares to treat chronic diseases in more personalized way PrecisionLife, developers of precision medicine for chronic diseases, will be supporting biopharmaceutical group, Sosei Heptares, to develop better, more personalized treatment options. Specifically, global techbio PrecisionLife, will assess the precision… November 9, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 29 Jun 2022 Encouraging results from respiratory diseases vaccine trial A biopharmaceutical company developing vaccines against infectious diseases has announced positive results for people with life threatening respiratory diseases. Icosavax says that in an interim phase 1/1b trial its vaccine… June 29, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2024 Trump’s healthcare picks: Who they are and what they mean for the biopharma industry …of over 95,000 children and confirmed that the MMR vaccine did not increase the risk for autism spectrum disorder. Moreover, vaccines have eradicated deadly diseases such as smallpox. The threat… November 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Expert Advice 27 May 2020 Why Listening to Patient Organizations is Key in Drug Development …space, it is still a challenge for patient organizations to get biotech and pharma companies involved in developing drugs for rare diseases. Because the majority of rare diseases are not… May 27, 2020 - 11 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
In Depth 15 Jan 2025 CRISPR: The gene editing tool changing the world (2025 update) …are already seeing CRISPR-based programs focusing on a wide diversity of diseases. CRISPR Therapeutics, for instance, in addition to Casgevy, is developing programs for cardiovascular diseases, type 1 diabetes, as… January 15, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Interview 5 Feb 2020 Harnessing Genetic Suppression to Treat Rare Disease …this genetic resilience to treat rare diseases and cancer. Heritable diseases result from genetic mutations that cause essential proteins in the body to malfunction. For example, people with the condition… February 5, 2020 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 13 Oct 2017 This French Biotech is Taking On CNS Diseases of the Young and the Elderly This week we’re in Castres in the South of France to visit Neurolixis. This biotech is taking on diseases of the CNS, such as Parkinson’s, depression and schizophrenia. Mission: Neurolixis… October 13, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jan 2018 Swedish Biotech Can Now Fast-Track its Metabolic Disorder Drug …metabolic disorder that affects children from a young age. It belongs to a group of diseases called Lysosomal Storage Disorders as the body cannot break down heparan sulfate, a long… January 23, 2018 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jul 2023 Lilly boosts obesity portfolio with Versanis Bio acquisition …on the development of new medicines for the treatment of cardiometabolic diseases. Versanis’ lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to… July 17, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 24 Feb 2023 Resalis Therapeutics receives €10M to develop obesity and NAFLD treatment Resalis Therapeutics has completed a seed financing round of €10 million to establish a non-coding RNA (ncRNA)-based therapeutic approach for the treatment of metabolic diseases. The funding will support the… February 24, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 Sep 2025 Top biotech deals in August 2025 …aimed at treating metabolic diseases like obesity and heart conditions. Superluminal can win up to $1.3 billion in upfront and milestone payments. German pharmaceutical Bayer and California-based cancer therapeutics company… September 9, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email